Functional role of nitric oxide in regulation of ocular blood flow

被引:73
作者
Koss, MC [1 ]
机构
[1] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA
关键词
nitric oxide (NO); eye; ocular blood flow; nitric oxide (NO) synthase; vascular physiology; ocular pathophysiology;
D O I
10.1016/S0014-2999(99)00242-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitric oxide generated by three distinct enzyme systems appears to play a critical role in many diverse physiological processes. Using both conventional and immunohistochemical techniques, nitric oxide synthases have been identified throughout the body, including all regions of the eye. A large number of in vitro and in vivo preparations have been utilized showing nitric oxide to have an important role in regulation of regional ocular blood flow. Nitric oxide-mediated control of basal ocular blood flow is demonstrated by vasoconstriction seen in experiments where vascular endothelial cells are removed, or when nitric oxide synthase is inhibited. The endogenous source of nitric oxide in the eye appears to be both endothelial and neural. In addition, administration of drugs that can 'donate' nitric oxide produces vasodilation of the eye vasculature. Local vasodilation in response to illumination of the retina is controlled by generation and release of nitric oxide, whereas most other physiological adjustments of ocular blood flow (i.e., autoregulation and responses to altered blood gas levels) seem to be relatively independent of nitric oxide mechanisms. Nitric oxide is implicated in a variety of ocular pathophysiological states including uveitis, retinal ischemic disease, diabetes and glaucoma. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:161 / 174
页数:14
相关论文
共 201 条
[1]   Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs [J].
Abran, D ;
Varma, DR ;
Chemtob, S .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (03) :R995-R1001
[2]   Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina [J].
Adachi, K ;
Fujita, Y ;
Morizane, C ;
Akaike, A ;
Ueda, M ;
Satoh, M ;
Masai, H ;
Kashii, S ;
Honda, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (01) :53-57
[3]   Diabetic retinopathy: Early functional changes [J].
Alder, VA ;
Su, EN ;
Yu, DY ;
Cringle, SJ ;
Yu, PK .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :785-788
[4]  
ALDER VA, 1993, INVEST OPHTH VIS SCI, V34, P49
[5]   Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis [J].
Allen, JB ;
McGahan, MC ;
Ferrell, JB ;
Adler, KB ;
Fleisher, LN .
EXPERIMENTAL EYE RESEARCH, 1996, 62 (01) :21-28
[6]  
Alm A., 1992, Adler's physiology of the eye, P198
[7]  
ALM P, 1995, HISTOCHEM J, V27, P819
[8]   GLIBENCLAMIDE AND L-N(G)-NITRO-ARGININE METHYL-ESTER MODULATE THE OCULAR AND HYPOTENSIVE EFFECTS OF CALCITONIN GENE-RELATED PEPTIDE [J].
ANDERSSON, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 224 (01) :89-91
[9]   ROLE OF NITRIC-OXIDE IN PGF(2-ALPHA)-INDUCED OCULAR HYPEREMIA [J].
ASTIN, M ;
STJERNSCHANTZ, J ;
SELEN, G .
EXPERIMENTAL EYE RESEARCH, 1994, 59 (04) :401-407
[10]   A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle [J].
Azuma, H ;
Masuda, H ;
Sato, J ;
Niwa, K ;
Tokoro, T .
EXPERIMENTAL EYE RESEARCH, 1997, 64 (05) :823-830